Reach the investors backing rounds like this
Backed by SynBioVen · verified emails and LinkedIn on Datapile
Imphatec raises £1.5M seed round for pill-free drug implants - Dealroom
Imphatec is a British synthetic biology pharmaceutical company developing a customizable-dose subcutaneous implant platform for patients with chronic and long-term conditions. The company aims to create a 'pill-free future' by providing implants that release personalized doses over the long term without patient input.
Imphatec raises £1.5M seed round for pill-free drug implants Dealroom
You just read who funded Imphatec. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.